Westfield Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-321,963
| Closed | -$45.6M | – | 234 |
|
|
2023
Q1 | $45.6M | Sell |
321,963
-103,011
| -24% | -$14.7M | 0.32% | 121 |
|
|
2022
Q4 | $66.5M | Buy |
424,974
+6,842
| +2% | +$983K | 0.51% | 69 |
|
|
2022
Q3 | $51.3M | Buy |
418,132
+4,753
| +1% | +$626K | 0.41% | 97 |
|
|
2022
Q2 | $55M | Sell |
413,379
-97,868
| -19% | -$13.3M | 0.43% | 85 |
|
|
2022
Q1 | $70M | Buy |
511,247
+71,345
| +16% | +$9.94M | 0.45% | 80 |
|
|
2021
Q4 | $76.1M | Buy |
439,902
+51,505
| +13% | +$7.84M | 0.45% | 78 |
|
|
2021
Q3 | $56.4M | Sell |
388,397
-589,913
| -60% | -$86.3M | 0.34% | 108 |
|
|
2021
Q2 | $129M | Buy |
978,310
+475,437
| +95% | +$62.2M | 0.77% | 30 |
|
|
2021
Q1 | $64.5M | Sell |
502,873
-523,415
| -51% | -$64.5M | 0.4% | 90 |
|
|
2020
Q4 | $122M | Buy |
1,026,288
+41,422
| +4% | +$5.05M | 0.73% | 39 |
|
|
2020
Q3 | $113M | Sell |
984,866
-10,698
| -1% | -$1.26M | 0.73% | 41 |
|
|
2020
Q2 | $113M | Buy |
995,564
+210,275
| +27% | +$22.3M | 0.78% | 34 |
|
|
2020
Q1 | $63.1M | Buy |
785,289
+256,860
| +49% | +$26.6M | 0.56% | 58 |
|
|
2019
Q4 | $56.4M | Buy |
528,429
+62,950
| +14% | +$6.56M | 0.4% | 91 |
|
|
2019
Q3 | $49.8M | Sell |
465,479
-7,272
| -2% | -$747K | 0.4% | 87 |
|
|
2019
Q2 | $48.1M | Sell |
472,751
-26,905
| -5% | -$2.59M | 0.36% | 99 |
|
|
2019
Q1 | $44.9M | Sell |
499,656
-27,295
| -5% | -$2.37M | 0.34% | 95 |
|
|
2018
Q4 | $43.9M | Sell |
526,951
-159,340
| -23% | -$14.9M | 0.37% | 87 |
|
|
2018
Q3 | $74.1M | Sell |
686,291
-26,642
| -4% | -$2.92M | 0.52% | 64 |
|
|
2018
Q2 | $78.4M | Buy |
712,933
+332,287
| +87% | +$34.6M | 0.59% | 54 |
|
|
2018
Q1 | $38.2M | Sell |
380,646
-20,830
| -5% | -$2.13M | 0.29% | 112 |
|
|
2017
Q4 | $39.5M | Sell |
401,476
-12,175
| -3% | -$1.15M | 0.3% | 128 |
|
|
2017
Q3 | $38.7M | Buy |
413,651
+48,742
| +13% | +$5.17M | 0.3% | 119 |
|
|
2017
Q2 | $40.6M | Sell |
364,909
-114,425
| -24% | -$12.1M | 0.35% | 104 |
|
|
2017
Q1 | $47.1M | Sell |
479,334
-210,847
| -31% | -$20.1M | 0.4% | 89 |
|
|
2016
Q4 | $63.4M | Buy |
690,181
+29,140
| +4% | +$2.51M | 0.56% | 59 |
|
|
2016
Q3 | $55.9M | Sell |
661,041
-173,505
| -21% | -$14.6M | 0.45% | 79 |
|
|
2016
Q2 | $67.9M | Sell |
834,546
-38,053
| -4% | -$2.9M | 0.56% | 57 |
|
|
2016
Q1 | $62.3M | Buy |
872,599
+229,774
| +36% | +$15.4M | 0.47% | 69 |
|
|
2015
Q4 | $45.7M | Buy |
642,825
+56,252
| +10% | +$3.78M | 0.31% | 107 |
|
|
2015
Q3 | $36.1M | Sell |
586,573
-9,581
| -2% | -$670K | 0.26% | 118 |
|
|
2015
Q2 | $43.2M | Sell |
596,154
-138,840
| -19% | -$10.3M | 0.26% | 117 |
|
|
2015
Q1 | $56.5M | Buy |
734,994
+37,335
| +5% | +$2.67M | 0.33% | 107 |
|
|
2014
Q4 | $46.8M | Buy |
697,659
+201,359
| +41% | +$12.7M | 0.28% | 115 |
|
|
2014
Q3 | $30.1M | Buy |
+496,300
| New | +$30.6M | 0.18% | 158 |
|
Other funds holding DGX
Westfield Capital Management's DGX Position: Q2 2023 in Review
Westfield Capital Management sold out of Quest Diagnostics (DGX) in Q2 2023, closing a stake of 321,963 shares — an estimated $45.6M sold.
Westfield Capital Management first reported a position in DGX in Q3 2014 and held it in 35 quarters. The position peaked at $129M in Q2 2021. 819 funds tracked by Wall St. Rank hold DGX as of Q2 2023.
- Westfield Capital Management reported no remaining Quest Diagnostics position as of Q2 2023 after selling out during the quarter.
- Westfield Capital Management sold 321,963 Quest Diagnostics shares in Q2 2023, an estimated $45.6M.
- Westfield Capital Management first reported a position in Quest Diagnostics in Q3 2014 and held it in 35 quarters.
- Westfield Capital Management's Quest Diagnostics position peaked at $129M in Q2 2021.
- 819 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.
Based on Westfield Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.